Navabi Mohammad Ali, Shabanian Reza, Kiani Abdolrazagh, Rahimzadeh Mitra
Department of Pediatric Cardiac Surgery, Imam Hospital, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
J Thorac Cardiovasc Surg. 2009 Aug;138(2):390-6. doi: 10.1016/j.jtcvs.2009.02.034. Epub 2009 May 5.
Our purpose was to evaluate the effect of ventricular septal defect enlargement on the early and late morbidity and mortality of patients undergoing Rastelli or Rastelli-type operations.
A total of 49 patients who underwent Rastelli or Rastelli-type operations between 1991 and 2007 were included in a retrospective follow-up study. Patients were divided into 2 groups: group A had ventricular septal defect enlargement, and group B did not have ventricular septal defect enlargement for comparison. Risk factor analysis for early or late death included patient-related and procedure-related variables, with failure, arrhythmia, and atrioventricular block as outcome parameters.
Median age and weight at the time of the operation were 6 years (range, 3 months-22 years) and 17 kg (range, 7-48 kg), respectively. The ventricular septal defect was enlarged in 28 (57%) patients. Ventricular septal defect enlargement showed a significant statistical relation with late ventricular dysfunction, arrhythmia, and residual ventricular septal defect (P = .023, P = .047, and P = .01, respectively, log-rank test). No relation was found between ventricular septal defect enlargement and permanent pacemaker implantation (P = .73, log-rank test). Furthermore, enlargement of the ventricular septal defect did not show any significant effect on the rate of early mortality (P = .69, Cox regression). Kaplan-Meier estimated survival for patients with ventricular septal defect enlargement was 74% at 5 years and 65% at 10 years. Freedom from late death in the group without ventricular septal defect enlargement was 100% at 5 and 10 years and 83% at 15 years. At a median follow-up of 4 years (range, 6 months-16 years), there were 12 late-onset deaths: 11 in group A (n = 28) and 1 in group B (n = 21). Ventricular septal defect enlargement greatly increased the risk of late death (P = .009, Cox regression).
Septal resection in patients undergoing Rastelli or Rastelli-type operations has a substantial effect on late morbidity and is a predictive factor for long-term mortality.
我们的目的是评估室间隔缺损扩大对接受Rastelli或Rastelli类手术患者的早期和晚期发病率及死亡率的影响。
对1991年至2007年间接受Rastelli或Rastelli类手术的49例患者进行回顾性随访研究。患者分为2组:A组存在室间隔缺损扩大,B组不存在室间隔缺损扩大以作比较。早期或晚期死亡的危险因素分析包括患者相关和手术相关变量,以衰竭、心律失常和房室传导阻滞作为结局参数。
手术时的中位年龄和体重分别为6岁(范围3个月至22岁)和17千克(范围7至48千克)。28例(57%)患者的室间隔缺损扩大。室间隔缺损扩大与晚期心室功能障碍、心律失常和残余室间隔缺损存在显著统计学关联(分别为P = 0.023、P = 0.047和P = 0.01,对数秩检验)。未发现室间隔缺损扩大与永久性起搏器植入之间存在关联(P = 0.73,对数秩检验)。此外,室间隔缺损扩大对早期死亡率未显示出任何显著影响(P = 0.69,Cox回归)。Kaplan-Meier估计,室间隔缺损扩大患者5年生存率为74%,10年生存率为65%。无室间隔缺损扩大组的晚期无死亡生存率在5年和10年时为100%,15年时为83%。中位随访4年(范围6个月至16年)时,有12例晚期死亡:A组(n = 28)11例,B组(n = 21)1例。室间隔缺损扩大显著增加了晚期死亡风险(P = 0.009,Cox回归)。
接受Rastelli或Rastelli类手术患者的间隔切除术对晚期发病率有重大影响,是长期死亡率的预测因素。